Cellectis S.A. (EPA:ALCLS)
France flag France · Delayed Price · Currency is EUR
3.210
-0.100 (-3.02%)
Mar 6, 2026, 3:19 PM CET

Cellectis Market Cap

Cellectis has a market cap or net worth of €239.40 million as of March 6, 2026. Its market cap has increased by 129.45% in one year.

Market Cap
239.40M
Enterprise Value
270.60M
Revenue
70.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.21

Market Cap Chart

Since February 7, 2007, Cellectis's market cap has increased from 100.59M to 239.40M, an increase of 137.98%. That is a compound annual growth rate of 4.65%.

History

DateMarket Cap% Change
Mar 5, 2026239.40M-21.10%
Dec 31, 2025303.40M158.68%
Dec 31, 2024117.29M-40.86%
Dec 29, 2023198.32M118.98%
Dec 30, 202290.57M-73.23%
Dec 31, 2021338.35M-67.37%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Transgene 233.30M
Genfit 435.46M
MaaT Pharma 131.34M
Innate Pharma 128.78M
Sensorion 128.25M
Adocia 126.57M
ABIONYX Pharma 114.83M
OSE Immunotherapeutics 91.03M
Market Cap Rankings